Michael Kaseta - Nov 4, 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Ira Duarte Attorney-in-fact for Michael Kaseta
Stock symbol
HRTX
Transactions as of
Nov 4, 2024
Transactions value $
$404,544
Form type
4
Date filed
11/6/2024, 02:08 PM
Previous filing
Oct 15, 2024
Next filing
Dec 3, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award +37.9K 37.9K Nov 4, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $405K +227K $1.78 227K Nov 4, 2024 Common Stock 227K $1.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (11/4/2024).
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant (11/4/2024).